Nortriptyline Treatment Protocol

Indications and Efficacy

Nortriptyline is commonly used for neuropathic pain management and depression, with the American Academy of Neurology and the American College of Physicians recommending it as a first-line treatment option due to its better side effect profile compared to other tricyclic antidepressants, with a moderate level of evidence supporting its efficacy 3, 1
For diabetic peripheral neuropathy, nortriptyline is typically dosed at 25-75 mg at bedtime, with a low to moderate level of evidence supporting its use in this population 4

The American Geriatrics Society recommends gradually increasing nortriptyline by 25 mg every 3-7 days as tolerated to minimize side effects, with a high level of evidence supporting this approach 1
For elderly patients, the American Geriatrics Society recommends using lower dosages (30-50 mg/day in divided doses), with a moderate level of evidence supporting this recommendation 2

Common adverse effects of nortriptyline include anticholinergic symptoms (dry mouth, constipation, urinary retention), with a high level of evidence supporting the association between nortriptyline and these side effects 3, 1
The American Heart Association recommends obtaining ECG screening for patients over 40 years before starting treatment, with a high level of evidence supporting the importance of cardiac monitoring in this population 2

The American College of Cardiology recommends using nortriptyline with caution in patients with cardiac disease, limiting doses to less than 100 mg/day when possible, with a moderate level of evidence supporting this recommendation 2
Secondary amine TCAs like nortriptyline have fewer anticholinergic side effects than tertiary amines like amitriptyline, with a low to moderate level of evidence supporting this comparison 1, 2

If partial pain relief is achieved, the American Academy of Neurology recommends adding another first-line medication from a different class (e.g., gabapentin or pregabalin), with a moderate level of evidence supporting this approach 2
If no or inadequate pain relief after an adequate trial, the American College of Physicians recommends switching to an alternative first-line medication, with a moderate level of evidence supporting this approach 3, 2

The American Academy of Neurology recommends monitoring for cardiac side effects, particularly in elderly patients or those with pre-existing cardiac conditions, with a high level of evidence supporting the importance of cardiac monitoring in this population 2
The American College of Physicians recommends assessing treatment response after 2-4 weeks at therapeutic doses, with a moderate level of evidence supporting this approach 2